Buyer: NIH Clinical Center 6707 Democracy Ste 106 MSC 5480 Bethesda MD 20892 Reference Number: CC263-13-Q-LV-5102 Required By: 01-11-13 Delivery By: 01-15-13 Delivery FOB: Y Small Business Set-aside: N FAR: 52.219-1 SMALL BUSINESS CONCERN REPRESENTATION 84041 SIC: 9999 FSC: 6640 Simplix Key: A3GQPOG0 Delivery Destination: NIH; 9000 Rockville Pike; Bethesda, MD 20892 LINE ITEM 01: 10 Each LABType SSO A Locus Kit LINE ITEM 02: 10 Each LABType SSO B Locus Kit LINE ITEM 03: 10 Each LABType SSO C Locus Kit LINE ITEM 04: 6 Each LABType SSO DQA/DQB Locus Kit LINE ITEM 05: 6 Each LABType SSO DRB345 Locus Kit LINE ITEM 06: 6 Each LABType SSO DRB1 Locus Kit LINE ITEM 07: 6 Vial(s) LABSCREEN Neg Control Serum LINE ITEM 08: 4 Vial(s) LABSCREEN IGG/PE LINE ITEM 09: 1 Each Shipping and Handling ADDITIONAL PROVISIONS AND REPRESENTATIONS: This is a Notice of Intent to award a sole-source purchase o rder and is not a request for competitve proposals under FAR 6.302-1 "Only one responsible source and no other supplies or services will satisfy agency requirements". The Governme nt intends to solicit a quote with One Lambda, Inc. Canoga P ark, CA 91303-2801, DUNS # 118289289 for ten (10) LabType SS O A Locus kits, ten (10) LabType SSO B Locus kits, ten (10) LabType C Locus kits, six (6) LabType SSO DQA/DQB Locus kits , six (6) LabType SSO DRB345 Locus kits, six (6) LabType SSO DRB1 Locus kits, six (6) LabScreen Neg Control Serum, four (4) LabScreen IGG/PE as well as shipping and handling. Due to the proprietary nature of this requirement, One Lambda, I nc is the only known manufacturer of the various LabType SSO /PRA class kits. These kits are used for routine HLA testin g and HLA antibody research for clinical purposes at the Nat ional Institutes of Health's Clinical Center. The Governement shall consider all responses received prior to the closing date of this procurement. Small businesses a re encouraged to respond if they are able to meet the needs of this requirement. Written responses to this notice shall contain sufficient documentation to establish bona fide cap ability to fulfill this requirement. The proposed award dat e will be on or before January 18, 2013. Please email Ivan Jones at [email protected] for questions pertaining to this notice.

Bid Protests Not Available